Barclays PLC Atai Life Sciences N.V. Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Barclays PLC holds 245,717 shares of ATAI stock, worth $265,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245,717
Previous 245,717
-0.0%
Holding current value
$265,374
Previous $484,000
32.44%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ATAI
# of Institutions
99Shares Held
12.8MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$2.98 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$2.94 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.41 Million0.0% of portfolio
-
Brown University719KShares$775,9800.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$774,5010.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $179M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...